90 results
Page 3 of 5
6-K
EX-99
sn3qhb4pvfn8cnfhr 8a
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B5
mb4800t3a41h1ija3nm
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
4pxn4sm rhud50gbsrc
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
azgaykxuaq2q 14sjjy
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
6g01j58cexi s6dpwfk
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
nn1it rddq4k7i6
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am
6-K
EX-99
i2f 5qdsz
5 Dec 19
BioLineRx Announces Preliminary Phase 2a Data from Triple
7:00am
6-K
EX-3
z0rrhyp9sno go
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-1
4tt7y6qazl d2g3
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
k08 omzotkviq2161
5 Nov 19
BioLineRx Announces BL-8040 in Combination with KEYTRUDA Shows Clinical Activity in Heavily Pretreated
9:00am
6-K
EX-99
26xg7gps
5 Nov 19
BioLineRx Presents Preclinical Data from Triple Combination
8:00am
6-K
EX-99
7z5xu
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
7hgf j6kxp7
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
8uzs0
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
0oicvh yu22ta0j6yjo
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
mdrjxixjqb6x2j357cc
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am
6-K
EX-99
r09dtodb2he6rjzmr
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
bd4nanhb28 0k5x9jk
22 Oct 18
Current report (foreign)
7:00am